StemCells to Start Small Trial of Brain Stem Cells

CHICAGO (Reuters) - Shares of StemCells Inc. rose 11 percent on Tuesday as the company announced plans to start an early-stage clinical trial involving the use of brain stem cells to treat Batten disease, a rare but fatal genetic disease that attacks the central nervous systems of children.

Continue to StemCells to Start Small Trial of Brain Stem Cells on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz